Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Cash & Equivalents (2019 - 2025)

Volitionrx's Cash & Equivalents history spans 8 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 65.78% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, down 65.78%, while the annual FY2025 figure was $1.1 million, 65.78% down from the prior year.
  • Cash & Equivalents reached $1.1 million in Q4 2025 per VNRX's latest filing, up from $199407.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $33.1 million in Q1 2021 to a low of $199407.0 in Q3 2025.
  • Average Cash & Equivalents over 5 years is $12.6 million, with a median of $10.8 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 559.07% in 2023, then plummeted 96.32% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $20.6 million in 2021, then tumbled by 47.2% to $10.9 million in 2022, then skyrocketed by 90.76% to $20.7 million in 2023, then tumbled by 84.25% to $3.3 million in 2024, then tumbled by 65.78% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Cash & Equivalents are $1.1 million (Q4 2025), $199407.0 (Q3 2025), and $2.3 million (Q2 2025).